window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

digital cognitive assessment

  • Clinical & Regulatory,Digital & Data,Research & Development,Therapeutic Areas

    Two-minute digital test matches clinical benchmarks for Alzheimer’s trial screening

    A two-minute digital cognitive assessment developed by Cumulus Neuroscience performed [...]

    July 15, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    From awareness to action: Linus Health drives next era of early brain health detection

    Linus Health is accelerating its efforts in early brain health [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Linus Health to present AI-driven brain health research at CTAD 2025

    Linus Health, an AI-driven brain health company focused on early [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Linus Health to showcase AI tools for brain health detection and trial recruitment at AAIC 2025

    Linus Health will present new findings on its AI-driven cognitive [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA grants Fast Track status to SOTIO’s colorectal cancer ADC ahead of Phase 1/2 trial
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • EpilepsyGTx partners with ClearPoint Neuro to support Phase 1 gene therapy trial
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Delivery & Formulation, Research & Development
  • Skyhawk expands global Huntington’s disease trial following positive Phase 1/2 data
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top